|
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
ICOM 3
ICOM 2
ICOM 1
|
|
|
LopezLopez, JR; PerezGarcia, MT; Canet, E; Gonzalez, C. 1998. Effects of almitrine bismesylate on the ionic currents of chemoreceptor cells from the carotid body. MOLECULAR PHARMACOLOGY 53(2):330-339.
Address:
C Gonzalez; UNIV VALLADOLID; FAC MED, DEPT BIOQUIM & BIOL MOL & FISIOL, SCH MED, C RAMON & CAJAL 7; VALLADOLID; SPAIN; 47005 AC
Almitrine is a drug used in the treatment of
hypoxemic chronic lung diseases such as bronchitis and
emphysema because it is a potent stimulant of the
carotid bodies in human and different animal species
that produces a long-lasting enhancement of alveolar
ventilation, ameliorating arterial blood gases.
However, the mechanism of action of almitrine remains
unknown. We investigated the effect of almitrine on
ionic currents of chemoreceptor cells isolated from the
carotid body of rat and rabbits by using the whole-cell
and inside-out configurations of the patch-clamp
technique. Almitrine at concentrations up to 10 mu M
did not affect whole-cell voltage-dependent K+, Ca2+,
or Na+ currents in rat or rabbit cells. However, this
concentration of almitrine significantly inhibited the
Ca2+-dependent component of K+ currents in rat
chemoreceptor cells. This effect of almitrine on the
Ca2+-dependent component of K+ currents was
investigated further at the single-channel level in
excised patches in the inside-out configuration. In
this preparation, almitrine inhibited the activity of a
high-conductance (152 +/- 13 pS), Ca2+-dependent K+
channel by decreasing its open probability. The IC50
value of the effect was 0.22 mu M. The inhibitory
effect of almitrine on Ca2+-dependent K+ channels also
was observed in GH3 cells. We conclude that almitrine
inhibits selectively the Ca2+-dependent K+ channel and
that in rat chemoreceptor cells, this inhibition could
represent an important mechanism of action underlying
the therapeutic actions of the drug.
|
|